86 research outputs found
Statistical Multifragmentation of Non-Spherical Expanding Sources in Central Heavy-Ion Collisions
We study the anisotropy effects measured with INDRA at GSI in central
collisions of Xe+Sn at 50 A.MeV and Au+Au at 60, 80, 100 A.MeV incident energy.
The microcanonical multifragmentation model with non-spherical sources is used
to simulate an incomplete shape relaxation of the multifragmenting system. This
model is employed to interpret observed anisotropic distributions in the
fragment size and mean kinetic energy. The data can be well reproduced if an
expanding prolate source aligned along the beam direction is assumed. An either
non-Hubblean or non-isotropic radial expansion is required to describe the
fragment kinetic energies and their anisotropy. The qualitative similarity of
the results for the studied reactions suggests that the concept of a
longitudinally elongated freeze-out configuration is generally applicable for
central collisions of heavy systems. The deformation decreases slightly with
increasing beam energy.Comment: 35 pages, 19 figures, submitted to Nuclear Physics
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.
BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362
ResistĂȘncia anti-helmĂntica em nematoides gastrintestinais de pequenos ruminantes: avanços e limitaçÔes para seu diagnĂłstico
A seleção e a crescente disseminação de nematoides resistentes aos anti-helmĂnticos mais comumente utilizados, benzimidazĂłis (BZs), imidazotiazĂłis e lactonas macrocĂclicas (LMs), constituem um sĂ©rio entrave na produção de pequenos ruminantes em todo o mundo. O uso de mĂ©todos eficientes e sensĂveis para a detecção e o monitoramento da resistĂȘncia anti-helmĂntica no campo torna-se urgente, especialmente para os grupos de BZs e LMs, devido aos constantes relatos de resistĂȘncia. A obtenção de um diagnĂłstico preciso e precoce da resistĂȘncia Ă© extremamente importante para auxiliar a tomada de decisĂŁo em programas de controle parasitĂĄrio, com o objetivo de preservar a vida Ăștil dos produtos e limitar o desenvolvimento da resistĂȘncia nas populaçÔes de nematoides. Os testes in vivo e, mais recentemente, os testes in vitro tĂȘm sido desenvolvidos para a detecção de nematoides resistentes aos principais grupos de anti-helmĂnticos. No entanto, a disponibilidade de testes in vitro validados e o seu uso prĂĄtico ainda sĂŁo muito limitados. Embora o teste de redução na contagem de ovos nas fezes (TRCOF, in vivo - indireto) seja o principal mĂ©todo de escolha para a detecção de resistĂȘncia no campo, vem recebendo crĂticas quanto Ă validade dos resultados, e passa por significativas modificaçÔes. AlĂ©m disso, o desenvolvimento de tĂ©cnicas moleculares a partir de alteraçÔes genĂŽmicas gerou avanços considerĂĄveis nessa ĂĄrea de investigação, com o uso de mutaçÔes nos cĂłdons 167, 198 e 200 do gene da ÎČ-tubulina como principais SNPs (polimorfismos de nucleotĂdeo Ășnico; do inglĂȘs Single Nucleotide Polymorphisms) associados Ă resistĂȘncia aos BZs. A presente revisĂŁo tem o objetivo de discutir os mĂ©todos de diagnĂłstico disponĂveis para a detecção de resistĂȘncia anti-helmĂntica em nematoides de pequenos ruminantes, destacando progressos e obstĂĄculos para seu uso na rotina laboratorial e no campo
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
Objective: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) following Phase
- âŠ